# Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa

> **NCT02774564** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 16 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** BIA 3-202
- **DRUG:** Placebo
- **DRUG:** Sinemet®

## Key facts

- **NCT ID:** NCT02774564
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02774564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02774564, "Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02774564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*